CymitQuimica logo

Nintedanib - Bio-X ™

CAS:

Ref. 3D-BN164249

100mg
Discontinued
10mg
Discontinued

Discontinued product. For inquiries about similar products, please fill out our form or email us at .

Nintedanib - Bio-X ™
Biosynth

Product Information

Name:Nintedanib - Bio-X ™
Synonyms:
  • Methyl (3Z)-3-{[(4-{methyl[(4-methylpiperazin-1-yl)acetyl]amino}phenyl)amino](phenyl)methylidene}-2-oxo-2,3-dihydro-1H-indole-6-carb oxylateOfevBIBF 1120Vargatef
Brand:Biosynth
Description:Nintedanib is an anti-inflammatory and anti-cancer drug. It is used for treatment of idiopathic pulmonary fibrosis. Nintedanib is a prodrug that is rapidly converted to the active form nintedanib, which inhibits angiogenesis by interfering with the activation of vascular endothelial growth factor receptor 1 (VEGFR1). Nintedanib is part of our Bio-X ™ Range. These products are aimed at life science researchers who need high quality ready to use products for assay development, screening or other R&D work. With a solubility datasheet and convenient vials, all of our Bio-X ™ products are in stock across our global warehouses for rapid delivery and ease of use.
Notice:Our products are intended for lab use only. For any other use, please contact us.

Chemical properties

Molecular weight:539.63 g/mol
Formula:C31H33O4N5
Purity:(%) Min. 95%
Color/Form:Yellow To Green-Yellow Solid
InChI:InChI=1S/C31H33N5O4/c1-34-15-17-36(18-16-34)20-27(37)35(2)24-12-10-23(11-13-24)32-29(21-7-5-4-6-8-21)28-25-14-9-22(31(39)40-3)19-26(25)33-30(28)38/h4-14,19,33,38H,15-18,20H2,1-3H3/b32-29+
InChI key:InChIKey=CPMDPSXJELVGJG-UUDCSCGESA-N
SMILES:COC(=O)c1ccc2c(/C(=N/c3ccc(N(C)C(=O)CN4CCN(C)CC4)cc3)c3ccccc3)c(O)[nH]c2c1

Inquiry about discontinued product: Nintedanib - Bio-X ™

◻️
CYMIT QUÍMICA, S.L. as responsible for the treatment will treat your data in order to respond to your queries or requests. You can access, rectify and delete your data, as well as exercise other rights by consulting the additional and detailed information on data protection in our Web Privacy Policy.
* Mandatory fields.